Oct. 28, 2024 — A strain of H5N1 avian influenza virus found in a Texas dairy worker who was infected this spring was able to spread among ferrets through the air, ... Aug. 19, 2024 — The ...

In August 2023, BD received FDA clearance for its BD Respiratory Viral Panel (RVP) for the BD MAXTM System. This innovative single molecular diagnostic combination test swiftly identified and ...

Sanofi Vietnam has cooperated with the VinaCapital Foundation (VCF) since April 2024 to implement a heart disease screening and influenza vaccination programme for people in Quang Binh and Tra Vinh ...

while VaxigripTetra is manufactured by Sanofi and locally distributed by Sanofi Aventis. Two other influenza vaccines that have been brought into Singapore for the Northern Hemisphere 2020/21 ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Wide-moat Sanofi reported better-than-expected third-quarter earnings driven by strong performance of the RSV prophylaxis drug Beyfortus and influenza vaccines. We've increased our fair value ...

Aside from Beyfortus, Sanofi’s other vaccines also showed growth in Q3, including its meningitis and influenza shots. “Our strong growth in the quarter was accelerated by the outstanding performance ...

Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...

As the Lower House election approaches this Sunday, a barrage of articles profuse with political labels is appearing in the media. But none of the articles explain what the labels mean ...